Smoking: Relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 2, 2008, Pages 105-109

  Pelkonen, Margit ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chronic bronchitis; Chronic obstructive pulmonary disease; Mortality; Pulmonary function; Smoking

Indexed keywords

ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATORY VOLUME; HIGH RISK POPULATION; HUMAN; MORTALITY; REVIEW; SMOKING; SMOKING CESSATION; SPIROMETRY;

BRONCHITIS, CHRONIC; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SURVIVAL RATE; WORLD HEALTH;

EID: 40049112098     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282f379e9     Document Type: Review

References (50)

1. Fletcher CM, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645-1648.
2. Viegi G, Paoletti P, Prediletto R, et al. Prevalence of respiratory symptoms in an unpolluted area of northern Italy. Eur Respir J 1988; 1:311-318.
3. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observation on male British doctors. BMJ 2004; 328:1519-1528.
4. Pelkonen M, Notkola I-L, Nisssinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD and chronic bronchitis in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130:1129-1137. In this paper, the 30-year cumulative incidence of chronic bronchitis (or COPD) was 42% (32%) in continuous smokers compared with 26% (14%) in ex-smokers and 22% (12%) in never-smokers. Chronic bronchitis was associated with an accelerated decline in lung function and mortality.
5. Lindberg A, Eriksson B, Larsson L-G, et al. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006; 129:779-885. This paper estimates the 7-year cumulative incidence of COPD in middle-aged and elderly individuals, and shows that chronic bronchitis is a risk factor for the development of COPD.
6. Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61:935-939. This study points out that the risk of developing clinically significant COPD in smokers is greater (at least 25%) than was previously estimated.
7. De Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007; 175:32-39. This paper shows that even in young adults the yearly incidence of COPD is substantial and individuals with chronic productive cough are at risk for developing COPD.
8. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006; 173:985-990. This paper studies risk factors for and outcomes of rapid lung function decline in adults aged 44-66 years.
9. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006; 61:472-477. This paper examines risk factors for and outcomes associated with rapid lung function decline in participants aged 65 years and older.
10. Stavem K, Sandvik L, Erikssen J. Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men. J Intern Med 2006; 260: 332-342.
11. Jensen HH, Godtfredsen NS, Lange P, et al. Potential misclassification of causes of death from COPD. Eur Respir J 2006; 28:781-785. This interesting paper describes causes of death in subjects with COPD and whether there is a bias in recording COPD as a cause of death.
12. Curkendall SM, deLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada. Cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16:63-70.
13. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58:388-393.
14. 1/FVC ratio (0.7) to define COPD in older populations identifies at-risk patients.
15. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease. A population based cohort study. Am J Respir Crit Care Med 2007; 175:458-463. This paper shows that regular physical activity may reduce the risk of developing COPD in smokers.
16. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tobacco Control 2006; 15:472-480.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease [ATS statement]. Am J Respir Crit Care Med 1995; 152:S77-S121.
18. Sethi JM, Rochester CL. Smoking and chronic obstructive pulmonary disease. Clin Chest Med 2000; 21:67-86.
19. Cerveri I, Accordini S, Verlato G, et al. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001; 18:85-92.
20. 1 decline and chronic obstructive pulmonary disease morbidity. The Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153:1530-1535.
21. Griffith KA, Sherrill DL, Siegel EM, et al. Predictors of loss of lung function in the elderly: the Cardiovascular Health Study. Am J Respir Crit Care Med 2001; 163:61-68.
22. Kauffman F, Drouet D, Lellouch J, et al. Twelve years spirometric changes among Paris area workers. Int J Epidemiol 1979; 8:201-212.
23. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398-1420.
24. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population. European Respiratory vs American Thoracic Society Definition. Chest 2000; 117:339S-345S.
25. British Thoracic Society. British Thoracic Society guidelines for the management of chronic obstructive pulmonary disease: the COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52:S1-S28.
26. Pauwels RA, Buist AS, Calverley PM, et al., and on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
27. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-535.
28. O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of metacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study. Am J Respir Crit Care Med 1995; 152:87-92.
29. Gottlieb DJ, Wilk JB, Harmon M, et al. Heritability of longitudinal change in lung function. The Framingham Study. Am J Respir Crit Care Med 2001; 164:1655-1659.
30. Gold DR, Wang X, Wypij D, et al. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996; 335:931-937.
31. Krzyzanowski M, Sherrill DL, Lebowitz MD. Longitudinal analysis of the effects of acute lower respiratory illnesses on pulmonary function in an adult population. Am J Epidemiol 1990; 131:412-422.
32. Hnizdo E, Sullivan PA, Bang KM, et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: A study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002; 156:738-746.
33. Ackermann-Liebrich U, Leuenberger P, Schwartz J, et al. Lung function and long term exposure to air pollutants in Switzerland. The Study on Air Pollution and Lung Diseases in Adults (SALPIDIA) Team. Am J Respir Crit Care Med 1997; 155:122-129.
34. Tabak C, Arts IC, Smit HA, et al. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones. The Morgen Study. Am J Respir Crit Care Med 2001; 164:61-64.
35. Burchfiel CM, Marcus EB, Sharp DS, et al. Characteristics associated with rapid decline in forced expiratory volume. Ann Epidemiol 1996; 6:217-227.
36. Pelkonen M, Notkola I-L, Lakka T, et al. Delaying decline in pulmonary function with physical activity. Am J Respir Crit Care Med 2003; 168:494-499.
37. Tager IB, Segal MR, Speizer FE, et al. The natural history of forced expiratory volumes. Effects of cigarette smoking and respiratory symptoms. Am Rev Respir Dis 1988; 138:837-849.
38. Xu X, Dockery DW, Ware JH, et al. Effects of cigarette smoking on rate loss of pulmonary function in adults: a longitudinal assessment. Am Rev Respir Dis 1992; 146:1345-1348.
39. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Heath Study. Am J Respir Crit Care Med 2000; 161:381-390.
40. Pelkonen M, Notkola I-L, Tukiainen H, et al. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 2001; 56:703-707.
41. Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45:579-585.
42. Hole DJ, Watt GCM, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711-715.
43. Pelkonen M, Tukiainen H, Tervahauta M, et al. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax 2000; 55:746-750.
44. Stavem K, Aaser E, Sandvik L, et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005; 25:618-625.
45. Rodriguez BL, Masaki K, Burchfiel C, et al. Pulmonary function decline and 17-year total mortality: the Honolulu Heart Program. Am J Epidemiol 1994; 140:398-408.
46. Ryan G, Knuiman MW, Divitini ML, et al. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health 1999; 53:230-234.
47. Lange P, Parner J, Prescott E, et al. Chronic bronchitis in an elderly population. Age Ageing 2003; 32:636-642.
48. Hewitt J, Smeeth L, Bulpitt CJ, et al. Respiratory symptoms in older people and their association with mortality. Thorax 2005; 60:331-334.
49. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128:491-500.
50. 1. Chest 1983; 83:717-724.